Compile Data Set for Download or QSAR
Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 8321
TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240864BDBM240864(US9394331, 127 | US9394331, 126)
Affinity DataEC50:  274nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240861BDBM240861(US9394331, 123)
Affinity DataEC50:  310nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240858BDBM240858(US9394331, 121 | US9394331, 120)
Affinity DataEC50:  390nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240866BDBM240866(US9394331, 129 | US9394331, 128)
Affinity DataEC50:  450nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240862BDBM240862(US9394331, 124)
Affinity DataEC50:  566nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240866BDBM240866(US9394331, 129 | US9394331, 128)
Affinity DataEC50:  670nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240860BDBM240860(US9394331, 122)
Affinity DataEC50:  857nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240856BDBM240856(US9394331, 119 | US9394331, 118)
Affinity DataEC50:  1.49E+3nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240855BDBM240855(US9394331, 113)
Affinity DataEC50:  1.55E+3nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240864BDBM240864(US9394331, 127 | US9394331, 126)
Affinity DataEC50:  3.10E+3nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240863BDBM240863(US9394331, 125)
Affinity DataEC50:  4.42E+3nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240856BDBM240856(US9394331, 119 | US9394331, 118)
Affinity DataEC50:  4.52E+3nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240845BDBM240845(US9394331, 140 | US9394331, 52)
Affinity DataEC50: >8.48E+3nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240868BDBM240868(US9394331, 131 | US9394331, 130)
Affinity DataEC50:  8.65E+3nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240858BDBM240858(US9394331, 121 | US9394331, 120)
Affinity DataEC50:  9.31E+3nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240868BDBM240868(US9394331, 131 | US9394331, 130)
Affinity DataEC50:  1.17E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240872BDBM240872(US9394331, 134)
Affinity DataEC50:  1.40E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240854BDBM240854(US9394331, 117)
Affinity DataEC50:  1.67E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240871BDBM240871(US9394331, 133)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240870BDBM240870(US9394331, 132)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240849BDBM240849(US9394331, 77)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240850BDBM240850(US9394331, 66)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240847BDBM240847(US9394331, 72)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240846BDBM240846(US9394331, 62)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240851BDBM240851(US9394331, 114)
Affinity DataEC50:  2.06E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240853BDBM240853(US9394331, 116)
Affinity DataEC50:  2.83E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240852BDBM240852(US9394331, 115)
Affinity DataEC50:  2.85E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240844BDBM240844(US9394331, 136 | US9394331, 48)
Affinity DataEC50:  3.94E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240843BDBM240843(US9394331, 137 | US9394331, 49)
Affinity DataEC50: >4.53E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240845BDBM240845(US9394331, 140 | US9394331, 52)
Affinity DataEC50: >5.45E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010,S282T](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240845BDBM240845(US9394331, 140 | US9394331, 52)
Affinity DataIC50: 5.67E+4nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240839BDBM240839(US9394331, 138 | US9394331, 50)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240840BDBM240840(US9394331, 36)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240838BDBM240838(US9394331, 135 | US9394331, 32)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010,S282T](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240844BDBM240844(US9394331, 136 | US9394331, 48)
Affinity DataIC50: 1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240848BDBM240848(US9394331, 76)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010,S282T](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240843BDBM240843(US9394331, 137 | US9394331, 49)
Affinity DataIC50: 1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240841BDBM240841(US9394331, 139 | US9394331, 51)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240843BDBM240843(US9394331, 137 | US9394331, 49)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240844BDBM240844(US9394331, 136 | US9394331, 48)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240839BDBM240839(US9394331, 138 | US9394331, 50)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240841BDBM240841(US9394331, 139 | US9394331, 51)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240838BDBM240838(US9394331, 135 | US9394331, 32)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandChemical structure of BindingDB Monomer ID 240842BDBM240842(US9394331, 44)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
US Patent